Please login to the form below
35
Revenue 2017Symbicort
The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Symbicort was produced by AstraZeneca and Astellas.
AZ's Symbicort suffers setback
AstraZeneca has been denied approval by the FDA for the use of its asthma drug Symbicort in children aged 6-11 years old. ... Symbicort was approved in the US for use in children over 12 years old for long-term maintenance of asthma in July 2009.
The PM Society Advertising Awards 2008
Highly commended: Zonegran by Big Pink for Eisai Ltd. Winner: Symbicort Smart.
PMEA 2008: Results and winners and pictures
by Pfizer. . Highly Commended. Symbicort SMART Launch. by AstraZeneca in association
Symbicort patent loss drags down AZ's share value
Symbicort racked up FY06 global sales of USD 1.2bn. The EU region accounted for USD 1bn of total sales. ... They also reduced estimates of Symbicort's 2012 sales in the EU region from USD 1.7bn to USD 599m.
Pharma news in brief
The US Food and Drug Administration (FDA) has approved AstraZeneca's (AZ) inhaled asthma drug, Symbicort, for the long-term treatment of patients aged 12 or over - a year earlier than ... AZ plans to market Symbicort in the US in mid-2007. Shares in AZ
[ Previous 5 results ] 4 5 6 7 8 9 10 11 12 13 [ Next 5 results ]
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Featured jobs
-
Midweight Brand Planner
-
Up to £50, 000
- Head of Partnerships - Competitive - London
-
Competitive Salary Offered
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
-
Senior Medical Writer
-
Salary TBC
Subscribe to our email news alerts
- Moving annual total (MAT)
- Grail’s multi-cancer blood test gets FDA breakthrough status
- Babylon expansion sparks ‘NHS destruction’ warnings
- Syncona launches another cell therapy company, Treg specialist Quell
- Spinraza managed access deal in England breaks deadlock for Biogen
- Positive mid-stage trial gives Allergy’s investors some welcome relief
- Latecomer Lilly preps its IL-23 drug for Crohn’s disease
- Merck bulks up in cancer with $2.2bn Peloton buy
- Transforming value and access outcomes in the Asia-Pacific region: a new market access study
- Verily unveils next-gen trials alliance with Novartis, Pfizer
- An increasingly polarised world offers the opportunity for healthcare organisations to build trust by turning inwards
- Focusing on patient-centricity to build trust in pharma
PMHub
Complete Medical Communications (CMC)
CMC is a leading global agency dedicated to healthcare communications across the lifecycle. We combine scientific acumen, excellence in delivery...
Latest intelligence
- The Exhibition Hall: Past, Present and Future
- As I sit here at another pharma conference, I start to reflect on how they have changed over the years....
- Success breeds success
- This week we received the exciting news that we have been shortlisted for the Times Business Awards 2019, Tunbridge Wells in the 'Best Business 1-25 Employees' category....
- Turning learning into action: The challenge of behaviour change
- ...
Quick links
Infographics
